19 results
8-K
EX-10.1
GOSS
Gossamer Bio Inc
20 Jul 23
Gossamer Bio Announces $212 Million Private Placement Financing
4:01pm
and federal environmental Laws (including Laws relating to the use, disposal or release of hazardous or toxic substances or relating to the protection … or restoration of the environment or human exposure to hazardous or toxic substances), and all applicable Laws enforced by the United States Food and Drug
8-K
EX-1.1
GOSS
Gossamer Bio Inc
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
relating to the release or threatened release of chemicals, pollutants, contaminants, wastes, toxic substances, hazardous substances, petroleum
8-K
EX-1.2
vq92h8kazj
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
8-K
EX-10.1
bawvsyjs8011xwc2h
3 May 19
Gossamer Bio Secures Debt Facility for Up to $150 Million
4:00pm
10-K
vwjiad6t
22 Mar 19
Annual report
4:45pm
424B4
buikbjc5wml7co
8 Feb 19
Prospectus supplement with pricing info
4:40pm
S-1/A
EX-1.1
veacd hi20
23 Jan 19
IPO registration (amended)
4:39pm
S-1/A
sdu0q3v 28vhbi2wkqmc
23 Jan 19
IPO registration (amended)
4:39pm
S-1
0twzosxai6 ftkmir
21 Dec 18
IPO registration
4:39pm
S-1
EX-10.15
9ejpyd6kn69r
21 Dec 18
IPO registration
4:39pm
DRS/A
zsti71j1d m4
29 Nov 18
Draft registration statement (amended)
12:00am
DRS
EX-10.11
xw8ftm166slmt1e0 q5
11 Oct 18
Draft registration statement
12:00am
DRS
y6d3u5b rzqb
11 Oct 18
Draft registration statement
12:00am
- Prev
- 1
- Next